The Cross-Border Biotech Blog

Screen Shot 2016-05-17 at 9.10.21 AM

Bloom Burton & Co. President also provides his sector outlook, advice for investors and top healthcare stock picks Click on the image to view the full video.

read more


SharePricePerformance_ViolatileanNegagiveinQ1_Part1-01

In order to assess share price performance among the Canadian public healthcare companies, I select companies at the beginning of each year which are categorized in two ways: share price to start the year and type of company. The total number of companies which will be assessed on a quarterly basis has increased from 99 […]

read more


Screen Shot 2016-05-01 at 9.54.42 PM

Brian Bloom discusses challenges facing Canada’s healthcare industry in Valeant’s shadow Click on the image to view the full video.

read more


Bloom Burton opens the TSX 2016

Bloom Burton opens the TSX ahead of the 2016 Bloom Burton Healthcare Investment Conference Click on the image to view the full video.

read more


Screen Shot 2016-04-29 at 11.14.55 AM

Bloom Burton’s analyst Dave Martin discusses Canadian healthcare risks and opportunities on BNN Click on the image to view the full video.

read more


Screen Shot 2016-04-28 at 3.26.53 PM

The Bloom Burton & Co. Healthcare Investor Conference highlighted in the Financial Post Click here to learn more about this preview of the Bloom Burton Healthcare Investor Conference in the Financial Post.

read more


Apollo_Part1

  Can Technology Improve Patient Adherence? In my last blog, On Being Unintentionally Non-Adherent, I left off proposing that there is a significant healthcare improvement opportunity if only we could increase the medication adherence amongst motivated patients, versus those who need serious behavioral modification. I also concluded that using technology to engage patients is the […]

read more


KeepingYourBunisess

If someone asks you how your business is doing, you may say “Great” or “Couldn’t be better”. But do you really know? Equally importantly, are you able to back up that comment and demonstrate the value of your business to an outside investor, lender or potential purchaser? You never know when you may need or […]

read more


Q4Annual2015PART3_SharePricePerformance-01

  In this blog, I am going to comment on the Q4 and 2015 annual performance of the Tier 2 group of 49 companies with share prices of between $0.10 and $0.99 to start 2015. IMRIS (taken private after a Chapter 11 filing), Premier Diagnostic Health Services (which no longer has a healthcare focus) and […]

read more